Casodex
Showing 1 - 25 of 116
Prostatic Tumors Trial in Toronto (hypoxia measurement)
Active, not recruiting
- Prostatic Neoplasms
- hypoxia measurement
-
Toronto, Ontario, CanadaPrincess Margaret Hospital
Oct 1, 2021
NAFLD, PCOS Trial in San Francisco (Bicalutamide 50 mg, Placebo)
Not yet recruiting
- NAFLD
- PCOS
- Bicalutamide 50 mg
- Placebo
-
San Francisco, CaliforniaUniversity of California San Francisco
Aug 4, 2023
Salivary Duct Carcinoma Trial in Nijmegen (Goserelin 10.8 mg, Bicalutamide 50 mg, Dutasteride 0.5 mg)
Not yet recruiting
- Salivary Duct Carcinoma
- Goserelin 10.8 mg
- +2 more
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Aug 23, 2022
Prostate Cancer Trial in Madison (Docetaxel, Degarelix, Bicalutamide)
Completed
- Prostate Cancer
- Docetaxel
- +3 more
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Sep 12, 2022
Prostate Cancer Trial in Washington, Baltimore (drug, procedure, radiation)
Completed
- Prostate Cancer
- Leuprolide Acetate
- +4 more
-
Washington, District of Columbia
- +2 more
Jul 11, 2022
Prostate Cancer Trial in Washington, Baltimore (Leuprolide Acetate, Docetaxel, Bicalutamide)
Active, not recruiting
- Prostate Cancer
- Leuprolide Acetate
- +4 more
-
Washington, District of Columbia
- +1 more
Mar 29, 2022
Prostate Cancer Trial in Chicago (Bicalutamide, Dutasteride, Finasteride)
Active, not recruiting
- Prostate Cancer
- Bicalutamide
- +3 more
-
Chicago, IllinoisUniversity of Chicago
Sep 30, 2021
Adenocarcinoma of the Prostate Trial in Sacramento (Stereotactic Radiosurgical Boost, Casodex, Leuprolide)
Recruiting
- Adenocarcinoma of the Prostate
- Stereotactic Radiosurgical Boost
- +2 more
-
Sacramento, CaliforniaUC Davis Sacramento Cancer Center Dept of Radiation Oncology
Sep 24, 2021
PSA Level Greater Than Two, Stage IV Prostate Adenocarcinoma AJCC v7 Trial in Duarte, South Pasadena (drug, radiation, other)
Active, not recruiting
- PSA Level Greater Than Two
- Stage IV Prostate Adenocarcinoma AJCC v7
- Bicalutamide
- +4 more
-
Duarte, California
- +1 more
Apr 4, 2022
COVID-19, SARS-CoV 2 Trial in Baltimore (Bicalutamide 150 Mg Oral Tablet)
Withdrawn
- COVID-19
- SARS-CoV 2
- Bicalutamide 150 Mg Oral Tablet
-
Baltimore, MarylandJohns Hopkins Hospital
Mar 2, 2021
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte
Recruiting
- Castration-Sensitive Prostate Carcinoma
- +4 more
- Abiraterone Acetate
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 7, 2022
Prostate Cancer, Bone Metastases, Prostate Tumors Trial in United States (LHRH agonist/antagonist, Bicalutamide, Radium-223
Terminated
- Prostate Cancer
- +2 more
- LHRH agonist/antagonist
- +2 more
-
Phoenix, Arizona
- +11 more
Jul 7, 2022
Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)
Active, not recruiting
- Prostate Adenocarcinoma
- Recurrent Prostate Carcinoma
- Abiraterone Acetate
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
High-risk Prostate Cancer, Prostate Cancer Trial in Houston (drug, radiation, procedure)
Recruiting
- High-risk Prostate Cancer
- Prostate Cancer
- HSV-Tk
- +5 more
-
Houston, TexasHouston Methodist Hospital
Apr 5, 2021
Prostate Cancer Trial in Philadelphia (drug, radiation, genetic)
Active, not recruiting
- Prostate Cancer
- Cabazitaxel
- +3 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Dec 7, 2020
Metastatic Breast Cancer Trial in France (AZD2014, AZD4547, AZD5363)
Active, not recruiting
- Metastatic Breast Cancer
- AZD2014
- +18 more
-
Angers, France
- +24 more
Mar 8, 2022
Prostatic Tumors Trial in Korea, Republic of (Leuprorelin, Goserelin, Triptorelin)
Recruiting
- Prostatic Neoplasms
- Leuprorelin
- +6 more
-
Cheongju, Korea, Republic of
- +9 more
Jul 28, 2021
Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Birmingham, Detroit, Columbus
Active, not recruiting
- Adenocarcinoma of the Prostate
- +2 more
- enzalutamide
- +5 more
-
Birmingham, Alabama
- +3 more
Mar 2, 2021
Prostate Cancer Trial in Madison (Bicalutamide and CP-675,206 (Tremelimumab), Bicalutamide, CP-675,206 (tremelimumab),
Terminated
- Prostate Cancer
- Bicalutamide and CP-675,206 (Tremelimumab)
- +3 more
-
Madison, WisconsinUniversity of Wisconsin Paul P. Carbone Comprehensive Cancer Cen
Nov 13, 2019
Prostate Cancer Trial in Shanghai (Bicalutamide, goserelin acetate, flutamide)
Active, not recruiting
- Prostate Cancer
- Bicalutamide
- +5 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 5, 2020
Prostate Cancer Trial in Houston (Flutamide, Leuprolide Acetate)
Terminated
- Prostate Cancer
- Flutamide
- Leuprolide Acetate
-
Houston, TexasUniversity of Texas - MD Anderson Cancer Center
Apr 20, 2020
Cognitive Functioning and Functional Status in Prostate Cancer
Active, not recruiting
- Prostate Cancer
- Questionaires
- fMRI scan (optional)
-
Duarte, California
- +1 more
Mar 18, 2022